CA3208717A1 - Single-chain and multi-chain synthetic antigen receptors for diverse immune cells - Google Patents
Single-chain and multi-chain synthetic antigen receptors for diverse immune cells Download PDFInfo
- Publication number
- CA3208717A1 CA3208717A1 CA3208717A CA3208717A CA3208717A1 CA 3208717 A1 CA3208717 A1 CA 3208717A1 CA 3208717 A CA3208717 A CA 3208717A CA 3208717 A CA3208717 A CA 3208717A CA 3208717 A1 CA3208717 A1 CA 3208717A1
- Authority
- CA
- Canada
- Prior art keywords
- cell
- domain
- sar
- receptor
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000006306 Antigen Receptors Human genes 0.000 title claims abstract description 32
- 108010008038 Synthetic Vaccines Proteins 0.000 title claims abstract description 28
- 210000002865 immune cell Anatomy 0.000 title claims description 19
- 239000000427 antigen Substances 0.000 claims abstract description 289
- 102000036639 antigens Human genes 0.000 claims abstract description 288
- 108091007433 antigens Proteins 0.000 claims abstract description 287
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 267
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 223
- 229920001184 polypeptide Polymers 0.000 claims abstract description 220
- 230000027455 binding Effects 0.000 claims abstract description 191
- 238000000034 method Methods 0.000 claims abstract description 130
- 102000005962 receptors Human genes 0.000 claims abstract description 121
- 108020003175 receptors Proteins 0.000 claims abstract description 121
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 111
- 239000013598 vector Substances 0.000 claims abstract description 56
- 239000012528 membrane Substances 0.000 claims abstract description 42
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 41
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 36
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 36
- 230000006870 function Effects 0.000 claims abstract description 23
- 102000004127 Cytokines Human genes 0.000 claims abstract description 20
- 108090000695 Cytokines Proteins 0.000 claims abstract description 20
- 102000003812 Interleukin-15 Human genes 0.000 claims abstract description 14
- 108090000172 Interleukin-15 Proteins 0.000 claims abstract description 14
- 230000004083 survival effect Effects 0.000 claims abstract description 14
- 108010002350 Interleukin-2 Proteins 0.000 claims abstract description 10
- 239000003550 marker Substances 0.000 claims abstract description 10
- 238000011282 treatment Methods 0.000 claims abstract description 10
- 206010010144 Completed suicide Diseases 0.000 claims abstract description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 346
- 210000004027 cell Anatomy 0.000 claims description 269
- 108091008874 T cell receptors Proteins 0.000 claims description 193
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 188
- 239000012634 fragment Substances 0.000 claims description 114
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 92
- 230000011664 signaling Effects 0.000 claims description 75
- 102000004169 proteins and genes Human genes 0.000 claims description 68
- 230000001086 cytosolic effect Effects 0.000 claims description 66
- -1 CD3y Proteins 0.000 claims description 63
- 210000000822 natural killer cell Anatomy 0.000 claims description 54
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 51
- 150000001413 amino acids Chemical group 0.000 claims description 50
- 239000003795 chemical substances by application Substances 0.000 claims description 46
- 206010028980 Neoplasm Diseases 0.000 claims description 45
- 230000014509 gene expression Effects 0.000 claims description 45
- 239000012636 effector Substances 0.000 claims description 43
- 210000004379 membrane Anatomy 0.000 claims description 40
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 37
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 34
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 34
- 210000004899 c-terminal region Anatomy 0.000 claims description 33
- 241000282414 Homo sapiens Species 0.000 claims description 28
- 201000011510 cancer Diseases 0.000 claims description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 27
- 102000040430 polynucleotide Human genes 0.000 claims description 27
- 108091033319 polynucleotide Proteins 0.000 claims description 27
- 239000002157 polynucleotide Substances 0.000 claims description 27
- 201000010099 disease Diseases 0.000 claims description 26
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims description 23
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims description 23
- 108060003951 Immunoglobulin Proteins 0.000 claims description 22
- 102000018358 immunoglobulin Human genes 0.000 claims description 22
- 230000004913 activation Effects 0.000 claims description 21
- 210000002540 macrophage Anatomy 0.000 claims description 19
- 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 claims description 18
- 102100029360 Hematopoietic cell signal transducer Human genes 0.000 claims description 18
- 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 claims description 18
- 101100226902 Mus musculus Fcrlb gene Proteins 0.000 claims description 18
- 239000003446 ligand Substances 0.000 claims description 17
- 102000049320 CD36 Human genes 0.000 claims description 16
- 108010045374 CD36 Antigens Proteins 0.000 claims description 16
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims description 16
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 16
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 16
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims description 16
- 102000027596 immune receptors Human genes 0.000 claims description 16
- 108091008915 immune receptors Proteins 0.000 claims description 16
- 210000000130 stem cell Anatomy 0.000 claims description 16
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 claims description 15
- 102100032852 Natural cytotoxicity triggering receptor 3 Human genes 0.000 claims description 15
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims description 15
- 239000012642 immune effector Substances 0.000 claims description 15
- 229940121354 immunomodulator Drugs 0.000 claims description 15
- 238000006467 substitution reaction Methods 0.000 claims description 15
- 102100029193 Low affinity immunoglobulin gamma Fc region receptor III-A Human genes 0.000 claims description 14
- 108010004222 Natural Cytotoxicity Triggering Receptor 3 Proteins 0.000 claims description 14
- 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 claims description 14
- 238000003776 cleavage reaction Methods 0.000 claims description 14
- 108020001507 fusion proteins Proteins 0.000 claims description 14
- 102000037865 fusion proteins Human genes 0.000 claims description 14
- 230000036961 partial effect Effects 0.000 claims description 14
- 230000007017 scission Effects 0.000 claims description 14
- 101000589305 Homo sapiens Natural cytotoxicity triggering receptor 2 Proteins 0.000 claims description 13
- 108010004217 Natural Cytotoxicity Triggering Receptor 1 Proteins 0.000 claims description 13
- 102100032851 Natural cytotoxicity triggering receptor 2 Human genes 0.000 claims description 13
- 230000007423 decrease Effects 0.000 claims description 13
- 102100027207 CD27 antigen Human genes 0.000 claims description 12
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 12
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 12
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 12
- 238000004873 anchoring Methods 0.000 claims description 12
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 12
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 11
- 102100027221 CD81 antigen Human genes 0.000 claims description 11
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 11
- 101000914479 Homo sapiens CD81 antigen Proteins 0.000 claims description 11
- 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 claims description 11
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims description 11
- 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 claims description 11
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims description 11
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims description 11
- 210000004443 dendritic cell Anatomy 0.000 claims description 11
- 210000001616 monocyte Anatomy 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 241000894007 species Species 0.000 claims description 11
- 101710117290 Aldo-keto reductase family 1 member C4 Proteins 0.000 claims description 10
- 230000003834 intracellular effect Effects 0.000 claims description 10
- 230000008685 targeting Effects 0.000 claims description 10
- 108020004414 DNA Proteins 0.000 claims description 9
- 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 claims description 9
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 9
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 9
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 9
- 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 claims description 9
- 102000000588 Interleukin-2 Human genes 0.000 claims description 9
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 9
- 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 claims description 9
- 210000003714 granulocyte Anatomy 0.000 claims description 9
- 210000000581 natural killer T-cell Anatomy 0.000 claims description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 8
- 101150013553 CD40 gene Proteins 0.000 claims description 8
- 101000633786 Homo sapiens SLAM family member 6 Proteins 0.000 claims description 8
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims description 8
- 101150069255 KLRC1 gene Proteins 0.000 claims description 8
- 241000713666 Lentivirus Species 0.000 claims description 8
- 101100404845 Macaca mulatta NKG2A gene Proteins 0.000 claims description 8
- 102000018697 Membrane Proteins Human genes 0.000 claims description 8
- 108010052285 Membrane Proteins Proteins 0.000 claims description 8
- 102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 claims description 8
- 102100029197 SLAM family member 6 Human genes 0.000 claims description 8
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims description 8
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 8
- 125000000539 amino acid group Chemical group 0.000 claims description 8
- 210000004405 cytokine-induced killer cell Anatomy 0.000 claims description 8
- 230000002147 killing effect Effects 0.000 claims description 8
- 101100044298 Drosophila melanogaster fand gene Proteins 0.000 claims description 7
- 101150064015 FAS gene Proteins 0.000 claims description 7
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims description 7
- 101100334515 Homo sapiens FCGR3A gene Proteins 0.000 claims description 7
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 claims description 7
- 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 claims description 7
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 claims description 7
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 7
- 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 claims description 7
- 101100335198 Pneumocystis carinii fol1 gene Proteins 0.000 claims description 7
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 claims description 7
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 7
- 101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 claims description 7
- 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 claims description 7
- 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims description 7
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims description 7
- 241000700605 Viruses Species 0.000 claims description 7
- 230000003213 activating effect Effects 0.000 claims description 7
- 230000000735 allogeneic effect Effects 0.000 claims description 7
- 108020001756 ligand binding domains Proteins 0.000 claims description 7
- 230000035755 proliferation Effects 0.000 claims description 7
- 102100024263 CD160 antigen Human genes 0.000 claims description 6
- 102100038077 CD226 antigen Human genes 0.000 claims description 6
- 102100024125 Embryonal Fyn-associated substrate Human genes 0.000 claims description 6
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 6
- 101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims description 6
- 101000884298 Homo sapiens CD226 antigen Proteins 0.000 claims description 6
- 101001053896 Homo sapiens Embryonal Fyn-associated substrate Proteins 0.000 claims description 6
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 6
- 101001027081 Homo sapiens Killer cell immunoglobulin-like receptor 2DL1 Proteins 0.000 claims description 6
- 101000945342 Homo sapiens Killer cell immunoglobulin-like receptor 2DS4 Proteins 0.000 claims description 6
- 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 claims description 6
- 101150074862 KLRC3 gene Proteins 0.000 claims description 6
- 101150018199 KLRC4 gene Proteins 0.000 claims description 6
- 102100037363 Killer cell immunoglobulin-like receptor 2DL1 Human genes 0.000 claims description 6
- 102100033624 Killer cell immunoglobulin-like receptor 2DS4 Human genes 0.000 claims description 6
- 102100022701 NKG2-E type II integral membrane protein Human genes 0.000 claims description 6
- 102100022700 NKG2-F type II integral membrane protein Human genes 0.000 claims description 6
- 102100035268 T-cell surface protein tactile Human genes 0.000 claims description 6
- 101710178300 Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 claims description 6
- 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 claims description 6
- 230000004927 fusion Effects 0.000 claims description 6
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 6
- 230000036039 immunity Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 230000028327 secretion Effects 0.000 claims description 6
- 230000001988 toxicity Effects 0.000 claims description 6
- 231100000419 toxicity Toxicity 0.000 claims description 6
- 102100038078 CD276 antigen Human genes 0.000 claims description 5
- 108010087819 Fc receptors Proteins 0.000 claims description 5
- 102000009109 Fc receptors Human genes 0.000 claims description 5
- 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 claims description 5
- 102100033627 Killer cell immunoglobulin-like receptor 3DL1 Human genes 0.000 claims description 5
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims description 5
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims description 5
- 102100021462 Natural killer cells antigen CD94 Human genes 0.000 claims description 5
- 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 claims description 5
- 102100023616 Neural cell adhesion molecule L1-like protein Human genes 0.000 claims description 5
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims description 5
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims description 5
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims description 5
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 5
- 210000000349 chromosome Anatomy 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 5
- 206010052015 cytokine release syndrome Diseases 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 5
- 208000015181 infectious disease Diseases 0.000 claims description 5
- 230000035772 mutation Effects 0.000 claims description 5
- 210000003289 regulatory T cell Anatomy 0.000 claims description 5
- 210000003705 ribosome Anatomy 0.000 claims description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 4
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 4
- 241000701022 Cytomegalovirus Species 0.000 claims description 4
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 4
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims description 4
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 4
- 102000003735 Mesothelin Human genes 0.000 claims description 4
- 108090000015 Mesothelin Proteins 0.000 claims description 4
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 4
- 230000004069 differentiation Effects 0.000 claims description 4
- 208000026278 immune system disease Diseases 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 210000003071 memory t lymphocyte Anatomy 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 3
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 3
- 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 claims description 3
- 108010065805 Interleukin-12 Proteins 0.000 claims description 3
- 102000013462 Interleukin-12 Human genes 0.000 claims description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical group C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- 101150028321 Lck gene Proteins 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- GQLCLPLEEOUJQC-ZTQDTCGGSA-N [(1r)-3-(3,4-dimethoxyphenyl)-1-[3-[2-[2-[[2-[3-[(1r)-3-(3,4-dimethoxyphenyl)-1-[(2s)-1-[(2s)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetyl]amino]ethylamino]-2-oxoethoxy]phenyl]propyl] (2s)-1-[(2s)-2-(3,4,5-trimethoxyph Chemical compound C([C@@H](OC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC)C=1C=C(OC)C(OC)=C(OC)C=1)C=1C=C(OCC(=O)NCCNC(=O)COC=2C=C(C=CC=2)[C@@H](CCC=2C=C(OC)C(OC)=CC=2)OC(=O)[C@H]2N(CCCC2)C(=O)[C@@H](CC)C=2C=C(OC)C(OC)=C(OC)C=2)C=CC=1)CC1=CC=C(OC)C(OC)=C1 GQLCLPLEEOUJQC-ZTQDTCGGSA-N 0.000 claims description 3
- 108091008034 costimulatory receptors Proteins 0.000 claims description 3
- 230000001419 dependent effect Effects 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 108091008042 inhibitory receptors Proteins 0.000 claims description 3
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 3
- 230000002062 proliferating effect Effects 0.000 claims description 3
- 108020001580 protein domains Proteins 0.000 claims description 3
- 125000006850 spacer group Chemical group 0.000 claims description 3
- 238000010361 transduction Methods 0.000 claims description 3
- 230000026683 transduction Effects 0.000 claims description 3
- 241000701161 unidentified adenovirus Species 0.000 claims description 3
- 241001430294 unidentified retrovirus Species 0.000 claims description 3
- 208000024827 Alzheimer disease Diseases 0.000 claims description 2
- 241000384062 Armadillo Species 0.000 claims description 2
- 108010014223 Armadillo Domain Proteins Proteins 0.000 claims description 2
- 102000000844 Cell Surface Receptors Human genes 0.000 claims description 2
- 108010001857 Cell Surface Receptors Proteins 0.000 claims description 2
- 241000702421 Dependoparvovirus Species 0.000 claims description 2
- 108010045579 Desmoglein 1 Proteins 0.000 claims description 2
- 102000007577 Desmoglein 3 Human genes 0.000 claims description 2
- 108010032035 Desmoglein 3 Proteins 0.000 claims description 2
- 102100034579 Desmoglein-1 Human genes 0.000 claims description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims description 2
- 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims description 2
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims description 2
- 108010075704 HLA-A Antigens Proteins 0.000 claims description 2
- 102000025850 HLA-A2 Antigen Human genes 0.000 claims description 2
- 108010074032 HLA-A2 Antigen Proteins 0.000 claims description 2
- 108010058607 HLA-B Antigens Proteins 0.000 claims description 2
- 108010052199 HLA-C Antigens Proteins 0.000 claims description 2
- 101000799466 Homo sapiens Thrombopoietin receptor Proteins 0.000 claims description 2
- 241001502974 Human gammaherpesvirus 8 Species 0.000 claims description 2
- 208000006994 Precancerous Conditions Diseases 0.000 claims description 2
- 102000036693 Thrombopoietin Human genes 0.000 claims description 2
- 108010041111 Thrombopoietin Proteins 0.000 claims description 2
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims description 2
- 208000026935 allergic disease Diseases 0.000 claims description 2
- 208000024908 graft versus host disease Diseases 0.000 claims description 2
- 230000003211 malignant effect Effects 0.000 claims description 2
- 230000001404 mediated effect Effects 0.000 claims description 2
- 230000001394 metastastic effect Effects 0.000 claims description 2
- 206010061289 metastatic neoplasm Diseases 0.000 claims description 2
- 239000013612 plasmid Substances 0.000 claims description 2
- 229950010131 puromycin Drugs 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 102000003298 tumor necrosis factor receptor Human genes 0.000 claims description 2
- 239000000833 heterodimer Substances 0.000 claims 15
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 claims 12
- 102100029198 SLAM family member 7 Human genes 0.000 claims 12
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims 10
- 101710188619 C-type lectin domain family 12 member A Proteins 0.000 claims 10
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 9
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims 9
- 238000003259 recombinant expression Methods 0.000 claims 9
- 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 claims 8
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims 8
- 108010025001 leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 claims 8
- 201000001441 melanoma Diseases 0.000 claims 7
- 230000019491 signal transduction Effects 0.000 claims 7
- 102000001301 EGF receptor Human genes 0.000 claims 6
- 108060006698 EGF receptor Proteins 0.000 claims 6
- 102100038083 Endosialin Human genes 0.000 claims 6
- 101100334524 Homo sapiens FCGR3B gene Proteins 0.000 claims 6
- 101000878602 Homo sapiens Immunoglobulin alpha Fc receptor Proteins 0.000 claims 6
- 102100038005 Immunoglobulin alpha Fc receptor Human genes 0.000 claims 6
- 102100034196 Thrombopoietin receptor Human genes 0.000 claims 6
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims 6
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 6
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims 6
- 239000005483 tyrosine kinase inhibitor Substances 0.000 claims 6
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 claims 6
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 5
- 102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 claims 5
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 5
- 101000945371 Homo sapiens Killer cell immunoglobulin-like receptor 2DL2 Proteins 0.000 claims 5
- 101000945333 Homo sapiens Killer cell immunoglobulin-like receptor 2DL3 Proteins 0.000 claims 5
- 101000945337 Homo sapiens Killer cell immunoglobulin-like receptor 2DL5A Proteins 0.000 claims 5
- 101000945335 Homo sapiens Killer cell immunoglobulin-like receptor 2DL5B Proteins 0.000 claims 5
- 101000945340 Homo sapiens Killer cell immunoglobulin-like receptor 2DS1 Proteins 0.000 claims 5
- 101000945490 Homo sapiens Killer cell immunoglobulin-like receptor 3DL2 Proteins 0.000 claims 5
- 101001049181 Homo sapiens Killer cell lectin-like receptor subfamily B member 1 Proteins 0.000 claims 5
- 101000971533 Homo sapiens Killer cell lectin-like receptor subfamily G member 1 Proteins 0.000 claims 5
- 101000650817 Homo sapiens Semaphorin-4D Proteins 0.000 claims 5
- 102100033599 Killer cell immunoglobulin-like receptor 2DL2 Human genes 0.000 claims 5
- 102100033634 Killer cell immunoglobulin-like receptor 2DL3 Human genes 0.000 claims 5
- 102100033629 Killer cell immunoglobulin-like receptor 2DL5A Human genes 0.000 claims 5
- 102100033628 Killer cell immunoglobulin-like receptor 2DL5B Human genes 0.000 claims 5
- 102100033631 Killer cell immunoglobulin-like receptor 2DS1 Human genes 0.000 claims 5
- 102100034840 Killer cell immunoglobulin-like receptor 3DL2 Human genes 0.000 claims 5
- 102100023678 Killer cell lectin-like receptor subfamily B member 1 Human genes 0.000 claims 5
- 102100021457 Killer cell lectin-like receptor subfamily G member 1 Human genes 0.000 claims 5
- 108010017736 Leukocyte Immunoglobulin-like Receptor B1 Proteins 0.000 claims 5
- 102100025584 Leukocyte immunoglobulin-like receptor subfamily B member 1 Human genes 0.000 claims 5
- 102100027744 Semaphorin-4D Human genes 0.000 claims 5
- 108010072917 class-I restricted T cell-associated molecule Proteins 0.000 claims 5
- RJBDSRWGVYNDHL-XNJNKMBASA-N (2S,4R,5S,6S)-2-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2R,3S)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-amino-6-[(1S,2R)-2-[(2S,4R,5S,6S)-5-amino-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-4-hydroxyoxane-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@@H](CO)O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@@H](O)\C=C\CCCCCCCCCCCCC RJBDSRWGVYNDHL-XNJNKMBASA-N 0.000 claims 4
- 102100029824 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Human genes 0.000 claims 4
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 4
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 4
- 102100026402 Adhesion G protein-coupled receptor E2 Human genes 0.000 claims 4
- 102100034159 Beta-3 adrenergic receptor Human genes 0.000 claims 4
- 108010051118 Bone Marrow Stromal Antigen 2 Proteins 0.000 claims 4
- 102100037086 Bone marrow stromal antigen 2 Human genes 0.000 claims 4
- 108700012439 CA9 Proteins 0.000 claims 4
- 102100029390 CMRF35-like molecule 1 Human genes 0.000 claims 4
- 102100024423 Carbonic anhydrase 9 Human genes 0.000 claims 4
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 4
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 4
- 102100038449 Claudin-6 Human genes 0.000 claims 4
- 108090000229 Claudin-6 Proteins 0.000 claims 4
- 241000709661 Enterovirus Species 0.000 claims 4
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims 4
- 101710116743 Ephrin type-A receptor 2 Proteins 0.000 claims 4
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 4
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims 4
- 102100031507 Fc receptor-like protein 5 Human genes 0.000 claims 4
- 102100036939 G-protein coupled receptor 20 Human genes 0.000 claims 4
- 101710108873 G-protein coupled receptor 20 Proteins 0.000 claims 4
- 102100021197 G-protein coupled receptor family C group 5 member D Human genes 0.000 claims 4
- 102000010956 Glypican Human genes 0.000 claims 4
- 108050001154 Glypican Proteins 0.000 claims 4
- 108050007237 Glypican-3 Proteins 0.000 claims 4
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 4
- 108010007712 Hepatitis A Virus Cellular Receptor 1 Proteins 0.000 claims 4
- 102100034459 Hepatitis A virus cellular receptor 1 Human genes 0.000 claims 4
- 101000794082 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Proteins 0.000 claims 4
- 101000780539 Homo sapiens Beta-3 adrenergic receptor Proteins 0.000 claims 4
- 101000884279 Homo sapiens CD276 antigen Proteins 0.000 claims 4
- 101100382122 Homo sapiens CIITA gene Proteins 0.000 claims 4
- 101000990055 Homo sapiens CMRF35-like molecule 1 Proteins 0.000 claims 4
- 101000884275 Homo sapiens Endosialin Proteins 0.000 claims 4
- 101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 claims 4
- 101001040713 Homo sapiens G-protein coupled receptor family C group 5 member D Proteins 0.000 claims 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 4
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims 4
- 101000945331 Homo sapiens Killer cell immunoglobulin-like receptor 2DL4 Proteins 0.000 claims 4
- 101000945339 Homo sapiens Killer cell immunoglobulin-like receptor 2DS2 Proteins 0.000 claims 4
- 101000945343 Homo sapiens Killer cell immunoglobulin-like receptor 2DS3 Proteins 0.000 claims 4
- 101000945351 Homo sapiens Killer cell immunoglobulin-like receptor 3DL1 Proteins 0.000 claims 4
- 101000945492 Homo sapiens Killer cell immunoglobulin-like receptor 3DS1 Proteins 0.000 claims 4
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 4
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims 4
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims 4
- 102100033633 Killer cell immunoglobulin-like receptor 2DL4 Human genes 0.000 claims 4
- 102100033630 Killer cell immunoglobulin-like receptor 2DS2 Human genes 0.000 claims 4
- 102100033625 Killer cell immunoglobulin-like receptor 2DS3 Human genes 0.000 claims 4
- 102100034833 Killer cell immunoglobulin-like receptor 3DS1 Human genes 0.000 claims 4
- 102000017578 LAG3 Human genes 0.000 claims 4
- 102100025586 Leukocyte immunoglobulin-like receptor subfamily A member 2 Human genes 0.000 claims 4
- 101710196509 Leukocyte immunoglobulin-like receptor subfamily A member 2 Proteins 0.000 claims 4
- 102100032129 Lymphocyte antigen 6K Human genes 0.000 claims 4
- 102100026371 MHC class II transactivator Human genes 0.000 claims 4
- 108700002010 MHC class II transactivator Proteins 0.000 claims 4
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 4
- 102100032364 Pannexin-3 Human genes 0.000 claims 4
- 101710165197 Pannexin-3 Proteins 0.000 claims 4
- 102100026181 Placenta-specific protein 1 Human genes 0.000 claims 4
- 108050005093 Placenta-specific protein 1 Proteins 0.000 claims 4
- 101710164680 Platelet-derived growth factor receptor beta Proteins 0.000 claims 4
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 4
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims 4
- 101710120463 Prostate stem cell antigen Proteins 0.000 claims 4
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 4
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims 4
- 108090000253 Thyrotropin Receptors Proteins 0.000 claims 4
- 102100029337 Thyrotropin receptor Human genes 0.000 claims 4
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 4
- 102000013532 Uroplakin II Human genes 0.000 claims 4
- 108010065940 Uroplakin II Proteins 0.000 claims 4
- 229940018964 belantamab mafodotin Drugs 0.000 claims 4
- 230000002950 deficient Effects 0.000 claims 4
- 108010072257 fibroblast activation protein alpha Proteins 0.000 claims 4
- 108010003374 fms-Like Tyrosine Kinase 3 Proteins 0.000 claims 4
- 229940022353 herceptin Drugs 0.000 claims 4
- 108091008039 hormone receptors Proteins 0.000 claims 4
- 229960004641 rituximab Drugs 0.000 claims 4
- 125000005630 sialyl group Chemical group 0.000 claims 4
- 102100024217 CAMPATH-1 antigen Human genes 0.000 claims 3
- 108010065524 CD52 Antigen Proteins 0.000 claims 3
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims 3
- 108010012236 Chemokines Proteins 0.000 claims 3
- 102000019034 Chemokines Human genes 0.000 claims 3
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 3
- 102000010449 Folate receptor beta Human genes 0.000 claims 3
- 108050001930 Folate receptor beta Proteins 0.000 claims 3
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 3
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims 3
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 3
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 3
- 102100033486 Lymphocyte antigen 75 Human genes 0.000 claims 3
- 101710157884 Lymphocyte antigen 75 Proteins 0.000 claims 3
- 102100034256 Mucin-1 Human genes 0.000 claims 3
- 102100025128 Olfactory receptor 51E2 Human genes 0.000 claims 3
- 101710187841 Olfactory receptor 51E2 Proteins 0.000 claims 3
- 206010065857 Primary Effusion Lymphoma Diseases 0.000 claims 3
- 206010039491 Sarcoma Diseases 0.000 claims 3
- 102100035748 Squamous cell carcinoma antigen recognized by T-cells 3 Human genes 0.000 claims 3
- 102100036494 Testisin Human genes 0.000 claims 3
- 108010000499 Thromboplastin Proteins 0.000 claims 3
- 102100030859 Tissue factor Human genes 0.000 claims 3
- 108040005514 choriogonadotropin hormone receptor activity proteins Proteins 0.000 claims 3
- 239000000539 dimer Substances 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 229940049679 trastuzumab deruxtecan Drugs 0.000 claims 3
- GRVDJDISBSALJP-FIBGUPNXSA-N trideuterio($l^{1}-oxidanyl)methane Chemical compound [2H]C([2H])([2H])[O] GRVDJDISBSALJP-FIBGUPNXSA-N 0.000 claims 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 claims 2
- 102100023990 60S ribosomal protein L17 Human genes 0.000 claims 2
- 101710109924 A-kinase anchor protein 4 Proteins 0.000 claims 2
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 claims 2
- 206010000830 Acute leukaemia Diseases 0.000 claims 2
- 101710096292 Adhesion G protein-coupled receptor E2 Proteins 0.000 claims 2
- 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 claims 2
- 102100024092 Aldo-keto reductase family 1 member C4 Human genes 0.000 claims 2
- 102100037982 Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Human genes 0.000 claims 2
- 102100026882 Alpha-synuclein Human genes 0.000 claims 2
- 102100032187 Androgen receptor Human genes 0.000 claims 2
- 102100023003 Ankyrin repeat domain-containing protein 30A Human genes 0.000 claims 2
- 101710145634 Antigen 1 Proteins 0.000 claims 2
- 102100030343 Antigen peptide transporter 2 Human genes 0.000 claims 2
- 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 claims 2
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims 2
- 102100023458 C-type lectin-like domain family 1 Human genes 0.000 claims 2
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 2
- 108010058905 CD44v6 antigen Proteins 0.000 claims 2
- 108060001253 CD99 Proteins 0.000 claims 2
- 102000024905 CD99 Human genes 0.000 claims 2
- 102100025805 Cadherin-1 Human genes 0.000 claims 2
- 102100024152 Cadherin-17 Human genes 0.000 claims 2
- 102100022529 Cadherin-19 Human genes 0.000 claims 2
- 102100029756 Cadherin-6 Human genes 0.000 claims 2
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims 2
- 102100039510 Cancer/testis antigen 2 Human genes 0.000 claims 2
- 102100021396 Cell surface glycoprotein CD200 receptor 1 Human genes 0.000 claims 2
- 102000011045 Chloride Channels Human genes 0.000 claims 2
- 102100039061 Cytokine receptor common subunit beta Human genes 0.000 claims 2
- 102100020986 DNA-binding protein RFX5 Human genes 0.000 claims 2
- 102100021044 DNA-binding protein RFXANK Human genes 0.000 claims 2
- 102100036466 Delta-like protein 3 Human genes 0.000 claims 2
- 101150029707 ERBB2 gene Proteins 0.000 claims 2
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 claims 2
- 101710144543 Endosialin Proteins 0.000 claims 2
- 108010001687 Enterotoxin Receptors Proteins 0.000 claims 2
- 102100023721 Ephrin-B2 Human genes 0.000 claims 2
- 108010044090 Ephrin-B2 Proteins 0.000 claims 2
- 102000010451 Folate receptor alpha Human genes 0.000 claims 2
- 108050001931 Folate receptor alpha Proteins 0.000 claims 2
- 102000027583 GPCRs class C Human genes 0.000 claims 2
- 108091008882 GPCRs class C Proteins 0.000 claims 2
- 102000003886 Glycoproteins Human genes 0.000 claims 2
- 108090000288 Glycoproteins Proteins 0.000 claims 2
- 101150112082 Gpnmb gene Proteins 0.000 claims 2
- 102100028113 Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Human genes 0.000 claims 2
- 102100022662 Guanylyl cyclase C Human genes 0.000 claims 2
- 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 claims 2
- 101710154606 Hemagglutinin Proteins 0.000 claims 2
- 208000017604 Hodgkin disease Diseases 0.000 claims 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 2
- 101000718211 Homo sapiens Adhesion G protein-coupled receptor E2 Proteins 0.000 claims 2
- 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 claims 2
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims 2
- 101000757191 Homo sapiens Ankyrin repeat domain-containing protein 30A Proteins 0.000 claims 2
- 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 claims 2
- 101000906643 Homo sapiens C-type lectin-like domain family 1 Proteins 0.000 claims 2
- 101000762247 Homo sapiens Cadherin-17 Proteins 0.000 claims 2
- 101000899410 Homo sapiens Cadherin-19 Proteins 0.000 claims 2
- 101000794604 Homo sapiens Cadherin-6 Proteins 0.000 claims 2
- 101000969553 Homo sapiens Cell surface glycoprotein CD200 receptor 1 Proteins 0.000 claims 2
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 claims 2
- 101001075432 Homo sapiens DNA-binding protein RFX5 Proteins 0.000 claims 2
- 101001075464 Homo sapiens DNA-binding protein RFXANK Proteins 0.000 claims 2
- 101000928513 Homo sapiens Delta-like protein 3 Proteins 0.000 claims 2
- 101001099051 Homo sapiens GPI inositol-deacylase Proteins 0.000 claims 2
- 101000916625 Homo sapiens Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Proteins 0.000 claims 2
- 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 claims 2
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims 2
- 101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 claims 2
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims 2
- 101000945346 Homo sapiens Killer cell immunoglobulin-like receptor 2DS5 Proteins 0.000 claims 2
- 101000971605 Homo sapiens Kita-kyushu lung cancer antigen 1 Proteins 0.000 claims 2
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims 2
- 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 claims 2
- 101000608935 Homo sapiens Leukosialin Proteins 0.000 claims 2
- 101001065550 Homo sapiens Lymphocyte antigen 6K Proteins 0.000 claims 2
- 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 claims 2
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims 2
- 101001023712 Homo sapiens Nectin-3 Proteins 0.000 claims 2
- 101001051490 Homo sapiens Neural cell adhesion molecule L1 Proteins 0.000 claims 2
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 2
- 101001136981 Homo sapiens Proteasome subunit beta type-9 Proteins 0.000 claims 2
- 101000979565 Homo sapiens Protein NLRC5 Proteins 0.000 claims 2
- 101001075466 Homo sapiens Regulatory factor X-associated protein Proteins 0.000 claims 2
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims 2
- 101000824971 Homo sapiens Sperm surface protein Sp17 Proteins 0.000 claims 2
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 claims 2
- 101000873927 Homo sapiens Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 claims 2
- 101000687808 Homo sapiens Suppressor of cytokine signaling 2 Proteins 0.000 claims 2
- 101000894428 Homo sapiens Transcriptional repressor CTCFL Proteins 0.000 claims 2
- 101000610605 Homo sapiens Tumor necrosis factor receptor superfamily member 10A Proteins 0.000 claims 2
- 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 claims 2
- 101001047681 Homo sapiens Tyrosine-protein kinase Lck Proteins 0.000 claims 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 2
- 241000701806 Human papillomavirus Species 0.000 claims 2
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 2
- 102100029616 Immunoglobulin lambda-like polypeptide 1 Human genes 0.000 claims 2
- 101710107067 Immunoglobulin lambda-like polypeptide 1 Proteins 0.000 claims 2
- 102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 claims 2
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 claims 2
- 102000004553 Interleukin-11 Receptors Human genes 0.000 claims 2
- 108010017521 Interleukin-11 Receptors Proteins 0.000 claims 2
- 102000003810 Interleukin-18 Human genes 0.000 claims 2
- 108090000171 Interleukin-18 Proteins 0.000 claims 2
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims 2
- 102100030704 Interleukin-21 Human genes 0.000 claims 2
- 102100036705 Interleukin-23 subunit alpha Human genes 0.000 claims 2
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 claims 2
- 102100033626 Killer cell immunoglobulin-like receptor 2DS5 Human genes 0.000 claims 2
- 102100021533 Kita-kyushu lung cancer antigen 1 Human genes 0.000 claims 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims 2
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims 2
- 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 claims 2
- 102100039564 Leukosialin Human genes 0.000 claims 2
- 101710158212 Lymphocyte antigen 6K Proteins 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 2
- 108010009254 Lysosomal-Associated Membrane Protein 1 Proteins 0.000 claims 2
- 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 claims 2
- 108010010995 MART-1 Antigen Proteins 0.000 claims 2
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 2
- 102100026712 Metalloreductase STEAP1 Human genes 0.000 claims 2
- 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 claims 2
- 101710141230 Natural killer cell receptor 2B4 Proteins 0.000 claims 2
- 102100035487 Nectin-3 Human genes 0.000 claims 2
- 102100035486 Nectin-4 Human genes 0.000 claims 2
- 101710043865 Nectin-4 Proteins 0.000 claims 2
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 2
- KUIFHYPNNRVEKZ-VIJRYAKMSA-N O-(N-acetyl-alpha-D-galactosaminyl)-L-threonine Chemical compound OC(=O)[C@@H](N)[C@@H](C)O[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O KUIFHYPNNRVEKZ-VIJRYAKMSA-N 0.000 claims 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 2
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 claims 2
- 102100037891 Plexin domain-containing protein 1 Human genes 0.000 claims 2
- 108050009432 Plexin domain-containing protein 1 Proteins 0.000 claims 2
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 2
- 102100035703 Prostatic acid phosphatase Human genes 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 102100035764 Proteasome subunit beta type-9 Human genes 0.000 claims 2
- 101710176177 Protein A56 Proteins 0.000 claims 2
- 102100023432 Protein NLRC5 Human genes 0.000 claims 2
- 102100038098 Protein-glutamine gamma-glutamyltransferase 5 Human genes 0.000 claims 2
- 108010024221 Proto-Oncogene Proteins c-bcr Proteins 0.000 claims 2
- 102000015690 Proto-Oncogene Proteins c-bcr Human genes 0.000 claims 2
- 102000005435 Receptor Tyrosine Kinase-like Orphan Receptors Human genes 0.000 claims 2
- 108010006700 Receptor Tyrosine Kinase-like Orphan Receptors Proteins 0.000 claims 2
- 102000005622 Receptor for Advanced Glycation End Products Human genes 0.000 claims 2
- 108010045108 Receptor for Advanced Glycation End Products Proteins 0.000 claims 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 2
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 2
- 102100021043 Regulatory factor X-associated protein Human genes 0.000 claims 2
- 102100027610 Rho-related GTP-binding protein RhoC Human genes 0.000 claims 2
- 102100038081 Signal transducer CD24 Human genes 0.000 claims 2
- 102100024784 Suppressor of cytokine signaling 2 Human genes 0.000 claims 2
- 101800001271 Surface protein Proteins 0.000 claims 2
- 101100215487 Sus scrofa ADRA2A gene Proteins 0.000 claims 2
- 101800000849 Tachykinin-associated peptide 2 Proteins 0.000 claims 2
- 101150117918 Tacstd2 gene Proteins 0.000 claims 2
- 102100028082 Tapasin Human genes 0.000 claims 2
- 108050003829 Testisin Proteins 0.000 claims 2
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 claims 2
- 101710148535 Thrombopoietin receptor Proteins 0.000 claims 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims 2
- 102000006601 Thymidine Kinase Human genes 0.000 claims 2
- 108020004440 Thymidine kinase Proteins 0.000 claims 2
- 102100021393 Transcriptional repressor CTCFL Human genes 0.000 claims 2
- 102100031989 Transmembrane protease serine 2 Human genes 0.000 claims 2
- 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 claims 2
- 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 claims 2
- 102100027212 Tumor-associated calcium signal transducer 2 Human genes 0.000 claims 2
- 108091005906 Type I transmembrane proteins Proteins 0.000 claims 2
- 102100024036 Tyrosine-protein kinase Lck Human genes 0.000 claims 2
- 208000002495 Uterine Neoplasms Diseases 0.000 claims 2
- 102100022748 Wilms tumor protein Human genes 0.000 claims 2
- 101710127857 Wilms tumor protein Proteins 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 108010034034 alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase Proteins 0.000 claims 2
- 108010080146 androgen receptors Proteins 0.000 claims 2
- 229960000455 brentuximab vedotin Drugs 0.000 claims 2
- 230000008878 coupling Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 229940127276 delta-like ligand 3 Drugs 0.000 claims 2
- WSFSSNUMVMOOMR-DICFDUPASA-N dideuteriomethanone Chemical compound [2H]C([2H])=O WSFSSNUMVMOOMR-DICFDUPASA-N 0.000 claims 2
- 108010051081 dopachrome isomerase Proteins 0.000 claims 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 2
- 201000003444 follicular lymphoma Diseases 0.000 claims 2
- 102000011778 gamma-delta T-Cell Antigen Receptors Human genes 0.000 claims 2
- 108010062214 gamma-delta T-Cell Antigen Receptors Proteins 0.000 claims 2
- PFJKOHUKELZMLE-VEUXDRLPSA-N ganglioside GM3 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 PFJKOHUKELZMLE-VEUXDRLPSA-N 0.000 claims 2
- 150000002270 gangliosides Chemical class 0.000 claims 2
- 230000003394 haemopoietic effect Effects 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 239000000185 hemagglutinin Substances 0.000 claims 2
- 201000005787 hematologic cancer Diseases 0.000 claims 2
- 102000006495 integrins Human genes 0.000 claims 2
- 108010044426 integrins Proteins 0.000 claims 2
- 108010074108 interleukin-21 Proteins 0.000 claims 2
- 229940043355 kinase inhibitor Drugs 0.000 claims 2
- 210000005075 mammary gland Anatomy 0.000 claims 2
- 101710135378 pH 6 antigen Proteins 0.000 claims 2
- 230000002688 persistence Effects 0.000 claims 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 2
- 108010043671 prostatic acid phosphatase Proteins 0.000 claims 2
- 206010038038 rectal cancer Diseases 0.000 claims 2
- 201000001275 rectum cancer Diseases 0.000 claims 2
- 230000002441 reversible effect Effects 0.000 claims 2
- 108010073531 rhoC GTP-Binding Protein Proteins 0.000 claims 2
- 102200006531 rs121913529 Human genes 0.000 claims 2
- 108010059434 tapasin Proteins 0.000 claims 2
- 210000001550 testis Anatomy 0.000 claims 2
- 108010058721 transglutaminase 5 Proteins 0.000 claims 2
- 206010046766 uterine cancer Diseases 0.000 claims 2
- SSOORFWOBGFTHL-OTEJMHTDSA-N (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-oxopentanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SSOORFWOBGFTHL-OTEJMHTDSA-N 0.000 claims 1
- 108020005345 3' Untranslated Regions Proteins 0.000 claims 1
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims 1
- 108010082808 4-1BB Ligand Proteins 0.000 claims 1
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 claims 1
- 101710168331 ALK tyrosine kinase receptor Proteins 0.000 claims 1
- 102100022907 Acrosin-binding protein Human genes 0.000 claims 1
- 101710107749 Acrosin-binding protein Proteins 0.000 claims 1
- 229940123702 Adenosine A2a receptor antagonist Drugs 0.000 claims 1
- 102100025668 Angiopoietin-related protein 3 Human genes 0.000 claims 1
- 102000009840 Angiopoietins Human genes 0.000 claims 1
- 108010009906 Angiopoietins Proteins 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 101100208111 Arabidopsis thaliana TRX5 gene Proteins 0.000 claims 1
- 102000030431 Asparaginyl endopeptidase Human genes 0.000 claims 1
- 241000228212 Aspergillus Species 0.000 claims 1
- 208000036170 B-Cell Marginal Zone Lymphoma Diseases 0.000 claims 1
- 208000032568 B-cell prolymphocytic leukaemia Diseases 0.000 claims 1
- 108010074708 B7-H1 Antigen Proteins 0.000 claims 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 1
- 108091007065 BIRCs Proteins 0.000 claims 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims 1
- 206010005949 Bone cancer Diseases 0.000 claims 1
- 208000018084 Bone neoplasm Diseases 0.000 claims 1
- 206010006143 Brain stem glioma Diseases 0.000 claims 1
- 208000011691 Burkitt lymphomas Diseases 0.000 claims 1
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims 1
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims 1
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 claims 1
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 claims 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims 1
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 claims 1
- 102000002110 C2 domains Human genes 0.000 claims 1
- 108050009459 C2 domains Proteins 0.000 claims 1
- 208000016778 CD4+/CD56+ hematodermic neoplasm Diseases 0.000 claims 1
- 108091008048 CMVpp65 Proteins 0.000 claims 1
- 101100518995 Caenorhabditis elegans pax-3 gene Proteins 0.000 claims 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 claims 1
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 claims 1
- 101710120600 Cancer/testis antigen 1 Proteins 0.000 claims 1
- 101710120595 Cancer/testis antigen 2 Proteins 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 108010051152 Carboxylesterase Proteins 0.000 claims 1
- 102000013392 Carboxylesterase Human genes 0.000 claims 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 claims 1
- 102100032616 Caspase-2 Human genes 0.000 claims 1
- 108090000552 Caspase-2 Proteins 0.000 claims 1
- 102100026550 Caspase-9 Human genes 0.000 claims 1
- 108090000566 Caspase-9 Proteins 0.000 claims 1
- 102100028914 Catenin beta-1 Human genes 0.000 claims 1
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 claims 1
- 102100034231 Cell surface A33 antigen Human genes 0.000 claims 1
- 206010007953 Central nervous system lymphoma Diseases 0.000 claims 1
- 101710181340 Chaperone protein DnaK2 Proteins 0.000 claims 1
- 108010062745 Chloride Channels Proteins 0.000 claims 1
- 101710128223 Chloride channel protein Proteins 0.000 claims 1
- 102100035167 Coiled-coil domain-containing protein 54 Human genes 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 241000711573 Coronaviridae Species 0.000 claims 1
- 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 claims 1
- 102000016736 Cyclin Human genes 0.000 claims 1
- 108050006400 Cyclin Proteins 0.000 claims 1
- 102000009902 Cytochrome P-450 CYP1B1 Human genes 0.000 claims 1
- 108010077090 Cytochrome P-450 CYP1B1 Proteins 0.000 claims 1
- 102000000311 Cytosine Deaminase Human genes 0.000 claims 1
- 108010080611 Cytosine Deaminase Proteins 0.000 claims 1
- 101100481408 Danio rerio tie2 gene Proteins 0.000 claims 1
- 150000004922 Dasatinib derivatives Chemical group 0.000 claims 1
- 101710088194 Dehydrogenase Proteins 0.000 claims 1
- 241000725619 Dengue virus Species 0.000 claims 1
- 101000903039 Drosophila melanogaster Deoxynucleoside kinase Proteins 0.000 claims 1
- 101100118093 Drosophila melanogaster eEF1alpha2 gene Proteins 0.000 claims 1
- 241001115402 Ebolavirus Species 0.000 claims 1
- 102100031334 Elongation factor 2 Human genes 0.000 claims 1
- 101710121417 Envelope glycoprotein Proteins 0.000 claims 1
- 102300064574 Epidermal growth factor receptor isoform 2 Human genes 0.000 claims 1
- 102000003951 Erythropoietin Human genes 0.000 claims 1
- 108090000394 Erythropoietin Proteins 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 108010008165 Etanercept Proteins 0.000 claims 1
- 206010061850 Extranodal marginal zone B-cell lymphoma (MALT type) Diseases 0.000 claims 1
- 108010060374 FSH Receptors Proteins 0.000 claims 1
- 102100027627 Follicle-stimulating hormone receptor Human genes 0.000 claims 1
- 102000003817 Fos-related antigen 1 Human genes 0.000 claims 1
- 108090000123 Fos-related antigen 1 Proteins 0.000 claims 1
- 108010084795 Fusion Oncogene Proteins Proteins 0.000 claims 1
- 102000005668 Fusion Oncogene Proteins Human genes 0.000 claims 1
- 102000044445 Galectin-8 Human genes 0.000 claims 1
- 108010015776 Glucose oxidase Proteins 0.000 claims 1
- 239000004366 Glucose oxidase Substances 0.000 claims 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 claims 1
- 102100035902 Glutamate decarboxylase 1 Human genes 0.000 claims 1
- 108010081687 Glutamate-cysteine ligase Proteins 0.000 claims 1
- 102100039696 Glutamate-cysteine ligase catalytic subunit Human genes 0.000 claims 1
- 102000006771 Gonadotropins Human genes 0.000 claims 1
- 108010086677 Gonadotropins Proteins 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims 1
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 claims 1
- 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 claims 1
- 102100031546 HLA class II histocompatibility antigen, DO beta chain Human genes 0.000 claims 1
- 108010010378 HLA-DP Antigens Proteins 0.000 claims 1
- 102000015789 HLA-DP Antigens Human genes 0.000 claims 1
- 108010062347 HLA-DQ Antigens Proteins 0.000 claims 1
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 1
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 1
- 108010024164 HLA-G Antigens Proteins 0.000 claims 1
- 101000691214 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 50S ribosomal protein L44e Proteins 0.000 claims 1
- 101710178419 Heat shock protein 70 2 Proteins 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 101000693085 Homo sapiens Angiopoietin-related protein 3 Proteins 0.000 claims 1
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 claims 1
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims 1
- 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 claims 1
- 101000983528 Homo sapiens Caspase-8 Proteins 0.000 claims 1
- 101000983523 Homo sapiens Caspase-9 Proteins 0.000 claims 1
- 101000996823 Homo sapiens Cell surface A33 antigen Proteins 0.000 claims 1
- 101000737052 Homo sapiens Coiled-coil domain-containing protein 54 Proteins 0.000 claims 1
- 101600123877 Homo sapiens Epidermal growth factor receptor (isoform 2) Proteins 0.000 claims 1
- 101000608769 Homo sapiens Galectin-8 Proteins 0.000 claims 1
- 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 claims 1
- 101000866281 Homo sapiens HLA class II histocompatibility antigen, DO beta chain Proteins 0.000 claims 1
- 101100232351 Homo sapiens IL12RB1 gene Proteins 0.000 claims 1
- 101000852870 Homo sapiens Interferon alpha/beta receptor 1 Proteins 0.000 claims 1
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims 1
- 101000852965 Homo sapiens Interleukin-1 receptor-like 2 Proteins 0.000 claims 1
- 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 claims 1
- 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 claims 1
- 101001055219 Homo sapiens Interleukin-9 receptor Proteins 0.000 claims 1
- 101001018097 Homo sapiens L-selectin Proteins 0.000 claims 1
- 101001098868 Homo sapiens Proprotein convertase subtilisin/kexin type 9 Proteins 0.000 claims 1
- 101000880770 Homo sapiens Protein SSX2 Proteins 0.000 claims 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 1
- 101100420560 Homo sapiens SLC39A6 gene Proteins 0.000 claims 1
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims 1
- 101001018021 Homo sapiens T-lymphocyte surface antigen Ly-9 Proteins 0.000 claims 1
- 101000835745 Homo sapiens Teratocarcinoma-derived growth factor 1 Proteins 0.000 claims 1
- 101000714168 Homo sapiens Testisin Proteins 0.000 claims 1
- 101000638154 Homo sapiens Transmembrane protease serine 2 Proteins 0.000 claims 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims 1
- 241000701027 Human herpesvirus 6 Species 0.000 claims 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 claims 1
- 241000829111 Human polyomavirus 1 Species 0.000 claims 1
- 101150102264 IE gene Proteins 0.000 claims 1
- 229940099539 IL-36 receptor antagonist Drugs 0.000 claims 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 claims 1
- 208000002979 Influenza in Birds Diseases 0.000 claims 1
- 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 claims 1
- 102100034349 Integrase Human genes 0.000 claims 1
- 102100025306 Integrin alpha-IIb Human genes 0.000 claims 1
- 101710149643 Integrin alpha-IIb Proteins 0.000 claims 1
- 102100036714 Interferon alpha/beta receptor 1 Human genes 0.000 claims 1
- 102100036697 Interleukin-1 receptor-like 2 Human genes 0.000 claims 1
- 102000003814 Interleukin-10 Human genes 0.000 claims 1
- 108090000174 Interleukin-10 Proteins 0.000 claims 1
- 102100020790 Interleukin-12 receptor subunit beta-1 Human genes 0.000 claims 1
- 102000003816 Interleukin-13 Human genes 0.000 claims 1
- 108090000176 Interleukin-13 Proteins 0.000 claims 1
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 claims 1
- 101710112634 Interleukin-13 receptor subunit alpha-2 Proteins 0.000 claims 1
- 108050003558 Interleukin-17 Proteins 0.000 claims 1
- 102000013691 Interleukin-17 Human genes 0.000 claims 1
- 108010065637 Interleukin-23 Proteins 0.000 claims 1
- 108010076561 Interleukin-23 Subunit p19 Proteins 0.000 claims 1
- 102000000743 Interleukin-5 Human genes 0.000 claims 1
- 108010002616 Interleukin-5 Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 102000004889 Interleukin-6 Human genes 0.000 claims 1
- 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 claims 1
- 102100026244 Interleukin-9 receptor Human genes 0.000 claims 1
- 241000710842 Japanese encephalitis virus Species 0.000 claims 1
- 102100034872 Kallikrein-4 Human genes 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 102100033467 L-selectin Human genes 0.000 claims 1
- 239000002067 L01XE06 - Dasatinib Substances 0.000 claims 1
- 239000002137 L01XE24 - Ponatinib Substances 0.000 claims 1
- 101150030213 Lag3 gene Proteins 0.000 claims 1
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims 1
- 206010023927 Lassa fever Diseases 0.000 claims 1
- 108010002481 Lymphocyte Specific Protein Tyrosine Kinase p56(lck) Proteins 0.000 claims 1
- 102000036243 Lymphocyte Specific Protein Tyrosine Kinase p56(lck) Human genes 0.000 claims 1
- 201000003791 MALT lymphoma Diseases 0.000 claims 1
- 102000016200 MART-1 Antigen Human genes 0.000 claims 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 108010058398 Macrophage Colony-Stimulating Factor Receptor Proteins 0.000 claims 1
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims 1
- 102100026046 Mannan-binding lectin serine protease 2 Human genes 0.000 claims 1
- 101710117460 Mannan-binding lectin serine protease 2 Proteins 0.000 claims 1
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims 1
- 241001115401 Marburgvirus Species 0.000 claims 1
- 241000712079 Measles morbillivirus Species 0.000 claims 1
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims 1
- 102000008840 Melanoma-associated antigen 1 Human genes 0.000 claims 1
- 108050000731 Melanoma-associated antigen 1 Proteins 0.000 claims 1
- 208000002030 Merkel cell carcinoma Diseases 0.000 claims 1
- 241000579048 Merkel cell polyomavirus Species 0.000 claims 1
- 102100025825 Methylated-DNA-protein-cysteine methyltransferase Human genes 0.000 claims 1
- 101710104913 Methylated-DNA-protein-cysteine methyltransferase Proteins 0.000 claims 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 claims 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 claims 1
- 208000003250 Mixed connective tissue disease Diseases 0.000 claims 1
- 108010008707 Mucin-1 Proteins 0.000 claims 1
- 241000235395 Mucor Species 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 241000711386 Mumps virus Species 0.000 claims 1
- 101100518997 Mus musculus Pax3 gene Proteins 0.000 claims 1
- 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 claims 1
- 101100369076 Mus musculus Tdgf1 gene Proteins 0.000 claims 1
- 101100481410 Mus musculus Tek gene Proteins 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 102100030124 N-myc proto-oncogene protein Human genes 0.000 claims 1
- 241000526636 Nipah henipavirus Species 0.000 claims 1
- 102000004459 Nitroreductase Human genes 0.000 claims 1
- 241000187654 Nocardia Species 0.000 claims 1
- 102000012547 Olfactory receptors Human genes 0.000 claims 1
- 108050002069 Olfactory receptors Proteins 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 240000007019 Oxalis corniculata Species 0.000 claims 1
- 108060006580 PRAME Proteins 0.000 claims 1
- 102000036673 PRAME Human genes 0.000 claims 1
- 102100040891 Paired box protein Pax-3 Human genes 0.000 claims 1
- 101710149060 Paired box protein Pax-3 Proteins 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 1
- 208000000821 Parathyroid Neoplasms Diseases 0.000 claims 1
- 201000011152 Pemphigus Diseases 0.000 claims 1
- 208000002471 Penile Neoplasms Diseases 0.000 claims 1
- 108010077519 Peptide Elongation Factor 2 Proteins 0.000 claims 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 claims 1
- 201000005746 Pituitary adenoma Diseases 0.000 claims 1
- 206010061538 Pituitary tumour benign Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 241000142787 Pneumocystis jirovecii Species 0.000 claims 1
- 108091036407 Polyadenylation Proteins 0.000 claims 1
- 102100037935 Polyubiquitin-C Human genes 0.000 claims 1
- 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 claims 1
- 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims 1
- 208000035416 Prolymphocytic B-Cell Leukemia Diseases 0.000 claims 1
- 102100038955 Proprotein convertase subtilisin/kexin type 9 Human genes 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 102000001253 Protein Kinase Human genes 0.000 claims 1
- 102100037686 Protein SSX2 Human genes 0.000 claims 1
- 229940116193 Protein phosphatase inhibitor Drugs 0.000 claims 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 claims 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 claims 1
- 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 claims 1
- 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 1
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 1
- 241000724205 Rice stripe tenuivirus Species 0.000 claims 1
- 241000606701 Rickettsia Species 0.000 claims 1
- 241000713124 Rift Valley fever virus Species 0.000 claims 1
- 241000315672 SARS coronavirus Species 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 101100174184 Serratia marcescens fosA gene Proteins 0.000 claims 1
- 101000629318 Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein Proteins 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 claims 1
- 102100037253 Solute carrier family 45 member 3 Human genes 0.000 claims 1
- 102100022441 Sperm surface protein Sp17 Human genes 0.000 claims 1
- 101710185775 Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims 1
- 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims 1
- 206010042971 T-cell lymphoma Diseases 0.000 claims 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 claims 1
- 102100033447 T-lymphocyte surface antigen Ly-9 Human genes 0.000 claims 1
- 101150002618 TCRP gene Proteins 0.000 claims 1
- 108010017842 Telomerase Proteins 0.000 claims 1
- 102100026404 Teratocarcinoma-derived growth factor 1 Human genes 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 201000005485 Toxoplasmosis Diseases 0.000 claims 1
- 102000004357 Transferases Human genes 0.000 claims 1
- 108090000992 Transferases Proteins 0.000 claims 1
- 101710081844 Transmembrane protease serine 2 Proteins 0.000 claims 1
- 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 claims 1
- 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 claims 1
- 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 claims 1
- 108091005956 Type II transmembrane proteins Proteins 0.000 claims 1
- 102000003425 Tyrosinase Human genes 0.000 claims 1
- 108060008724 Tyrosinase Proteins 0.000 claims 1
- 102100022596 Tyrosine-protein kinase ABL1 Human genes 0.000 claims 1
- 101710098624 Tyrosine-protein kinase ABL1 Proteins 0.000 claims 1
- 108010056354 Ubiquitin C Proteins 0.000 claims 1
- 208000023915 Ureteral Neoplasms Diseases 0.000 claims 1
- 206010046458 Urethral neoplasms Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 201000003761 Vaginal carcinoma Diseases 0.000 claims 1
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 claims 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 1
- 241000710886 West Nile virus Species 0.000 claims 1
- 108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 claims 1
- 241000907316 Zika virus Species 0.000 claims 1
- 102100023144 Zinc transporter ZIP6 Human genes 0.000 claims 1
- 239000012082 adaptor molecule Substances 0.000 claims 1
- 239000002467 adenosine A2a receptor antagonist Substances 0.000 claims 1
- 208000024447 adrenal gland neoplasm Diseases 0.000 claims 1
- QLTCHMYAEJEXBT-UHFFFAOYSA-N alpha-beta-D-glucopyranosyloxy-isobutyronitrile Natural products N#CC(C)(C)OC1OC(CO)C(O)C(O)C1O QLTCHMYAEJEXBT-UHFFFAOYSA-N 0.000 claims 1
- 239000000611 antibody drug conjugate Substances 0.000 claims 1
- 229940049595 antibody-drug conjugate Drugs 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 108010055066 asparaginylendopeptidase Proteins 0.000 claims 1
- 206010064097 avian influenza Diseases 0.000 claims 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims 1
- 230000033228 biological regulation Effects 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- 208000035269 cancer or benign tumor Diseases 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000003915 cell function Effects 0.000 claims 1
- 230000011748 cell maturation Effects 0.000 claims 1
- 210000000170 cell membrane Anatomy 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 208000025997 central nervous system neoplasm Diseases 0.000 claims 1
- 208000019065 cervical carcinoma Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 claims 1
- 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 claims 1
- 108010079940 cyanogenic beta-glucosidase Proteins 0.000 claims 1
- 229960002448 dasatinib Drugs 0.000 claims 1
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims 1
- 229940121551 donanemab Drugs 0.000 claims 1
- 229940073621 enbrel Drugs 0.000 claims 1
- 210000000750 endocrine system Anatomy 0.000 claims 1
- 201000003914 endometrial carcinoma Diseases 0.000 claims 1
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 claims 1
- 229940105423 erythropoietin Drugs 0.000 claims 1
- 201000001343 fallopian tube carcinoma Diseases 0.000 claims 1
- 229940116862 faricimab Drugs 0.000 claims 1
- 101150078861 fos gene Proteins 0.000 claims 1
- 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 238000012239 gene modification Methods 0.000 claims 1
- 230000005017 genetic modification Effects 0.000 claims 1
- 235000013617 genetically modified food Nutrition 0.000 claims 1
- 229940116332 glucose oxidase Drugs 0.000 claims 1
- 235000019420 glucose oxidase Nutrition 0.000 claims 1
- 239000002622 gonadotropin Substances 0.000 claims 1
- 201000009277 hairy cell leukemia Diseases 0.000 claims 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 102000048448 human CASP8 Human genes 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 208000037797 influenza A Diseases 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 235000013902 inosinic acid Nutrition 0.000 claims 1
- 108040001304 interleukin-17 receptor activity proteins Proteins 0.000 claims 1
- 102000053460 interleukin-17 receptor activity proteins Human genes 0.000 claims 1
- 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 claims 1
- 108040006852 interleukin-4 receptor activity proteins Proteins 0.000 claims 1
- 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 108010024383 kallikrein 4 Proteins 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- QLTCHMYAEJEXBT-ZEBDFXRSSA-N linamarin Chemical compound N#CC(C)(C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QLTCHMYAEJEXBT-ZEBDFXRSSA-N 0.000 claims 1
- CRTWQTRFSBJGLK-UHFFFAOYSA-N linamarin Natural products CC(C)(C#N)C1OC(CO)C(O)C(O)C1O CRTWQTRFSBJGLK-UHFFFAOYSA-N 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 229950009758 loncastuximab tesirine Drugs 0.000 claims 1
- 230000001589 lymphoproliferative effect Effects 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 208000026037 malignant tumor of neck Diseases 0.000 claims 1
- 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims 1
- 208000021937 marginal zone lymphoma Diseases 0.000 claims 1
- 229950009794 mosunetuzumab Drugs 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 108091008800 n-Myc Proteins 0.000 claims 1
- 210000004897 n-terminal region Anatomy 0.000 claims 1
- 108020001162 nitroreductase Proteins 0.000 claims 1
- 229960003301 nivolumab Drugs 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 210000002990 parathyroid gland Anatomy 0.000 claims 1
- 229960002621 pembrolizumab Drugs 0.000 claims 1
- 201000001976 pemphigus vulgaris Diseases 0.000 claims 1
- 239000003934 phosphoprotein phosphatase inhibitor Substances 0.000 claims 1
- 208000021310 pituitary gland adenoma Diseases 0.000 claims 1
- 208000007525 plasmablastic lymphoma Diseases 0.000 claims 1
- 210000005134 plasmacytoid dendritic cell Anatomy 0.000 claims 1
- PHXJVRSECIGDHY-UHFFFAOYSA-N ponatinib Chemical compound C1CN(C)CCN1CC(C(=C1)C(F)(F)F)=CC=C1NC(=O)C1=CC=C(C)C(C#CC=2N3N=CC=CC3=NC=2)=C1 PHXJVRSECIGDHY-UHFFFAOYSA-N 0.000 claims 1
- 229960001131 ponatinib Drugs 0.000 claims 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 208000016800 primary central nervous system lymphoma Diseases 0.000 claims 1
- 230000001686 pro-survival effect Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 201000001514 prostate carcinoma Diseases 0.000 claims 1
- 108010079891 prostein Proteins 0.000 claims 1
- 102000016914 ras Proteins Human genes 0.000 claims 1
- 230000007115 recruitment Effects 0.000 claims 1
- 201000007444 renal pelvis carcinoma Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 229940121500 spesolimab Drugs 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 108010088201 squamous cell carcinoma-related antigen Proteins 0.000 claims 1
- 208000017572 squamous cell neoplasm Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 229940121503 tafasitamab Drugs 0.000 claims 1
- 229940121623 teclistamab Drugs 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 108010029307 thymic stromal lymphopoietin Proteins 0.000 claims 1
- 229940104230 thymidine Drugs 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 206010043778 thyroiditis Diseases 0.000 claims 1
- 229950007123 tislelizumab Drugs 0.000 claims 1
- 230000002463 transducing effect Effects 0.000 claims 1
- 230000032258 transport Effects 0.000 claims 1
- 229950007217 tremelimumab Drugs 0.000 claims 1
- 230000005747 tumor angiogenesis Effects 0.000 claims 1
- 241000701447 unidentified baculovirus Species 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
- 210000000626 ureter Anatomy 0.000 claims 1
- 108010047303 von Willebrand Factor Proteins 0.000 claims 1
- 102100036537 von Willebrand factor Human genes 0.000 claims 1
- 208000013013 vulvar carcinoma Diseases 0.000 claims 1
- 238000013461 design Methods 0.000 abstract description 13
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 239000013256 coordination polymer Substances 0.000 description 304
- 235000001014 amino acid Nutrition 0.000 description 44
- 235000018102 proteins Nutrition 0.000 description 43
- 230000000139 costimulatory effect Effects 0.000 description 42
- 229940024606 amino acid Drugs 0.000 description 41
- 210000004962 mammalian cell Anatomy 0.000 description 36
- 230000004068 intracellular signaling Effects 0.000 description 27
- 101710173835 Penton protein Proteins 0.000 description 15
- 125000003275 alpha amino acid group Chemical group 0.000 description 13
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 13
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 12
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 102000001708 Protein Isoforms Human genes 0.000 description 9
- 108010029485 Protein Isoforms Proteins 0.000 description 9
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 230000001413 cellular effect Effects 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 7
- 230000004071 biological effect Effects 0.000 description 7
- 238000002659 cell therapy Methods 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 102000035160 transmembrane proteins Human genes 0.000 description 7
- 108091005703 transmembrane proteins Proteins 0.000 description 7
- 108010075254 C-Peptide Proteins 0.000 description 6
- 102100039694 Death-associated protein 1 Human genes 0.000 description 6
- 241001648840 Thosea asigna virus Species 0.000 description 6
- DFVKOWFGNASVPK-BWHPXCRDSA-N [cyano-(4-phenoxyphenyl)methyl] (1s,3s)-3-[(z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)OC(C#N)C(C=C1)=CC=C1OC1=CC=CC=C1 DFVKOWFGNASVPK-BWHPXCRDSA-N 0.000 description 6
- 238000002784 cytotoxicity assay Methods 0.000 description 6
- 231100000263 cytotoxicity test Toxicity 0.000 description 6
- 230000028993 immune response Effects 0.000 description 6
- 102000035025 signaling receptors Human genes 0.000 description 6
- 108091005475 signaling receptors Proteins 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 5
- 108010083359 Antigen Receptors Proteins 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000009630 liquid culture Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000000440 neutrophil Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 3
- 102000002090 Fibronectin type III Human genes 0.000 description 3
- 108050009401 Fibronectin type III Proteins 0.000 description 3
- 102000016844 Immunoglobulin-like domains Human genes 0.000 description 3
- 108050006430 Immunoglobulin-like domains Proteins 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 230000006044 T cell activation Effects 0.000 description 3
- 210000000612 antigen-presenting cell Anatomy 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000001461 cytolytic effect Effects 0.000 description 3
- 238000006471 dimerization reaction Methods 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000001024 immunotherapeutic effect Effects 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 102000042628 natural cytotoxicity receptor (NCR) family Human genes 0.000 description 3
- 108091053394 natural cytotoxicity receptor (NCR) family Proteins 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 2
- NSBGUMKAXUXKGI-BPNHAYRBSA-N AP20187 Chemical compound C([C@@H](OC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC)C=1C=C(OC)C(OC)=C(OC)C=1)C=1C=C(OCC(=O)NCC(CNC(=O)COC=2C=C(C=CC=2)[C@@H](CCC=2C=C(OC)C(OC)=CC=2)OC(=O)[C@H]2N(CCCC2)C(=O)[C@@H](CC)C=2C=C(OC)C(OC)=C(OC)C=2)CN(C)C)C=CC=1)CC1=CC=C(OC)C(OC)=C1 NSBGUMKAXUXKGI-BPNHAYRBSA-N 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 108090000342 C-Type Lectins Proteins 0.000 description 2
- 102000003930 C-Type Lectins Human genes 0.000 description 2
- 108700010070 Codon Usage Proteins 0.000 description 2
- 102100022132 High affinity immunoglobulin epsilon receptor subunit gamma Human genes 0.000 description 2
- 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 2
- 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000824104 Homo sapiens High affinity immunoglobulin epsilon receptor subunit gamma Proteins 0.000 description 2
- 101001117312 Homo sapiens Programmed cell death 1 ligand 2 Proteins 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 2
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 101100007739 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) crmA gene Proteins 0.000 description 2
- 108700012920 TNF Proteins 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 101150044878 US18 gene Proteins 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000005754 cellular signaling Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 238000002825 functional assay Methods 0.000 description 2
- 238000001476 gene delivery Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000001823 molecular biology technique Methods 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 210000004986 primary T-cell Anatomy 0.000 description 2
- 229950004008 rimiducid Drugs 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 102220241871 rs140296303 Human genes 0.000 description 2
- 102000034285 signal transducing proteins Human genes 0.000 description 2
- 108091006024 signal transducing proteins Proteins 0.000 description 2
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000016904 Armadillo Domain Proteins Human genes 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 1
- 102100032412 Basigin Human genes 0.000 description 1
- 238000011357 CAR T-cell therapy Methods 0.000 description 1
- 101710185679 CD276 antigen Proteins 0.000 description 1
- 101100067721 Caenorhabditis elegans gly-3 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 description 1
- 201000005488 Capillary Leak Syndrome Diseases 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 108010002947 Connectin Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
- 101001055158 Felis catus Interleukin-15 Proteins 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241001669573 Galeorhinus galeus Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 101150090209 HCST gene Proteins 0.000 description 1
- 102000011786 HLA-A Antigens Human genes 0.000 description 1
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 1
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 description 1
- 101000746783 Homo sapiens Cytochrome b-c1 complex subunit 6, mitochondrial Proteins 0.000 description 1
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 1
- 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 1
- 101001055157 Homo sapiens Interleukin-15 Proteins 0.000 description 1
- 101100495232 Homo sapiens MS4A1 gene Proteins 0.000 description 1
- 101000589301 Homo sapiens Natural cytotoxicity triggering receptor 1 Proteins 0.000 description 1
- 101000589307 Homo sapiens Natural cytotoxicity triggering receptor 3 Proteins 0.000 description 1
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 101000801255 Homo sapiens Tumor necrosis factor receptor superfamily member 17 Proteins 0.000 description 1
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 108010073816 IgE Receptors Proteins 0.000 description 1
- 102000009438 IgE Receptors Human genes 0.000 description 1
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
- 102100022339 Integrin alpha-L Human genes 0.000 description 1
- 102100025390 Integrin beta-2 Human genes 0.000 description 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108010043610 KIR Receptors Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000043131 MHC class II family Human genes 0.000 description 1
- 108091054438 MHC class II family Proteins 0.000 description 1
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 1
- 101710150918 Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000714177 Murine leukemia virus Species 0.000 description 1
- 101100508818 Mus musculus Inpp5k gene Proteins 0.000 description 1
- 208000014767 Myeloproliferative disease Diseases 0.000 description 1
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 description 1
- 101800000135 N-terminal protein Proteins 0.000 description 1
- 230000006051 NK cell activation Effects 0.000 description 1
- 102000027581 NK cell receptors Human genes 0.000 description 1
- 108091008877 NK cell receptors Proteins 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 108091005461 Nucleic proteins Chemical group 0.000 description 1
- 101800001452 P1 proteinase Proteins 0.000 description 1
- 102100035031 Palladin Human genes 0.000 description 1
- 101710128215 Palladin Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108010079855 Peptide Aptamers Proteins 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 241001144416 Picornavirales Species 0.000 description 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
- 208000007541 Preleukemia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 101100366438 Rattus norvegicus Sphkap gene Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000712907 Retroviridae Species 0.000 description 1
- 108091027967 Small hairpin RNA Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 208000031932 Systemic capillary leak syndrome Diseases 0.000 description 1
- 230000006052 T cell proliferation Effects 0.000 description 1
- 102100029452 T cell receptor alpha chain constant Human genes 0.000 description 1
- 241000249107 Teschovirus A Species 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- 102100026260 Titin Human genes 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
- 101150110932 US19 gene Proteins 0.000 description 1
- 108010046882 ZAP-70 Protein-Tyrosine Kinase Proteins 0.000 description 1
- 102000007624 ZAP-70 Protein-Tyrosine Kinase Human genes 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000011467 adoptive cell therapy Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 108700010039 chimeric receptor Proteins 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000004940 costimulation Effects 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 108010057085 cytokine receptors Proteins 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000012645 endogenous antigen Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005167 everolimus Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 102000048638 human UQCRH Human genes 0.000 description 1
- 102000053880 human mitochondria proteolipid-like Human genes 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000005931 immune cell recruitment Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 102000028557 immunoglobulin binding proteins Human genes 0.000 description 1
- 108091009323 immunoglobulin binding proteins Proteins 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 108040006732 interleukin-1 receptor activity proteins Proteins 0.000 description 1
- 102000014909 interleukin-1 receptor activity proteins Human genes 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940045426 kymriah Drugs 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000005980 lung dysfunction Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 210000005170 neoplastic cell Anatomy 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
- 239000013643 reference control Substances 0.000 description 1
- 230000015696 regulation of natural killer cell activation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 108010087686 src-Family Kinases Proteins 0.000 description 1
- 102000009076 src-Family Kinases Human genes 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 108010078373 tisagenlecleucel Proteins 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 108091007466 transmembrane glycoproteins Proteins 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- QSLPNSWXUQHVLP-FIBGUPNXSA-N trideuterio($l^{1}-sulfanyl)methane Chemical compound [2H]C([2H])([2H])[S] QSLPNSWXUQHVLP-FIBGUPNXSA-N 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/17—Monocytes; Macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/31—Chimeric antigen receptors [CAR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/421—Immunoglobulin superfamily
- A61K40/4211—CD19 or B4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/421—Immunoglobulin superfamily
- A61K40/4212—CD22, BL-CAM, siglec-2 or sialic acid binding Ig-related lectin 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/4214—Receptors for cytokines
- A61K40/4215—Receptors for tumor necrosis factors [TNF], e.g. lymphotoxin receptor [LTR], CD30
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/4221—CD20
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4267—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K40/4269—NY-ESO
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
- A61K2239/48—Blood cells, e.g. leukemia or lymphoma
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Mycology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163151421P | 2021-02-19 | 2021-02-19 | |
| US63/151,421 | 2021-02-19 | ||
| US202163245181P | 2021-09-16 | 2021-09-16 | |
| US63/245,181 | 2021-09-16 | ||
| PCT/US2022/017177 WO2022178367A2 (en) | 2021-02-19 | 2022-02-21 | Single-chain and multi-chain synthetic antigen receptors for diverse immune cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3208717A1 true CA3208717A1 (en) | 2022-08-25 |
Family
ID=82932320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3208717A Pending CA3208717A1 (en) | 2021-02-19 | 2022-02-21 | Single-chain and multi-chain synthetic antigen receptors for diverse immune cells |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240390496A1 (enExample) |
| EP (1) | EP4297769A2 (enExample) |
| JP (1) | JP2024518011A (enExample) |
| KR (1) | KR20230153529A (enExample) |
| AU (1) | AU2022224066A1 (enExample) |
| CA (1) | CA3208717A1 (enExample) |
| IL (1) | IL305175A (enExample) |
| WO (1) | WO2022178367A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2898210T3 (es) | 2017-07-14 | 2022-03-04 | Immatics Biotechnologies Gmbh | Molécula de polipéptido con especificidad dual mejorada |
| JP7368856B2 (ja) | 2017-07-25 | 2023-10-25 | トゥルーバインディング,インコーポレイテッド | Tim-3とそのリガンドとの相互作用の遮断によるがん治療 |
| EA202092945A1 (ru) * | 2018-06-01 | 2021-04-29 | Юниверсити Оф Саутерн Калифорния | Различные антигенсвязывающие домены, новые платформы и другие улучшения для клеточной терапии |
| CN116063505B (zh) | 2019-01-30 | 2024-05-03 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| CA3174575A1 (en) * | 2020-03-02 | 2021-09-10 | The Regents Of The University Of California | Chimeric antigen receptors and related methods and compositions for the treatment of cancer |
| US12281166B2 (en) | 2020-05-26 | 2025-04-22 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking Galectin-3 |
| JP2024516699A (ja) | 2021-05-05 | 2024-04-16 | イマティクス バイオテクノロジーズ ゲーエムベーハー | Bma031抗原結合ポリペプチド |
| EP4334361A1 (en) | 2021-05-05 | 2024-03-13 | Immatics Biotechnologies GmbH | Antigen binding proteins specifically binding prame |
| AR130387A1 (es) * | 2022-09-08 | 2024-12-04 | Hoffmann La Roche | Receptores de linfocitos t recombinantes |
| CN118146393A (zh) * | 2022-11-07 | 2024-06-07 | 武汉波睿达生物科技有限公司 | 一种信号肽序列优化的靶向cd19的嵌合抗原受体及其应用 |
| WO2024102954A1 (en) * | 2022-11-10 | 2024-05-16 | Massachusetts Institute Of Technology | Activation induced clipping system (aics) |
| KR20250133399A (ko) * | 2023-01-05 | 2025-09-05 | 앤젤레스 테라퓨틱스, 인코포레이티드 | 유전자 전달 및 합성 및 면역 수용체의 활성을 제어하기 위한 방법 및 조성물 |
| SE2350348A1 (en) * | 2023-03-28 | 2024-09-29 | Bjoerefeldt Andreas | Microglial endocytic receptors for use in the treatment of neurodegenerative disease |
| AU2024266421A1 (en) * | 2023-05-01 | 2025-11-06 | Regeneron Pharmaceuticals, Inc. | Mutant interleukin 15 expressing immune cells |
| WO2024238962A1 (en) * | 2023-05-18 | 2024-11-21 | A2 Biotherapeutics, Inc. | Immune cells with paired receptors and uses thereof |
| WO2025029597A1 (en) * | 2023-07-28 | 2025-02-06 | Nkilt Therapeutics, Inc. | Chimeric ilt receptor compositions and methods |
| AU2024220135A1 (en) * | 2023-09-28 | 2025-04-17 | PELL Bio-Med Technology Co., Ltd. | ISOLATED NUCLEIC ACID MOLECULE COMPRISING NKp30 TRANSMEMBRANE DOMAIN AND CHIMERIC ANTIGEN RECEPTOR COMPRISING THE SAME |
| WO2025193475A1 (en) * | 2024-03-14 | 2025-09-18 | The Regents Of The University Of California | Enhancing immune cell innate and adaptive responses |
| WO2025194049A1 (en) * | 2024-03-15 | 2025-09-18 | Dana-Farber Cancer Institute, Inc. | Engineered immune cells and methods of using the same |
| WO2025235862A1 (en) * | 2024-05-10 | 2025-11-13 | Inndura Therapeutics Inc. | A modified immune cell receptor comprising a target-binding domain and the extracellular domain of cd16a |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2350415A1 (en) * | 1998-11-18 | 2000-05-25 | Incyte Pharmaceuticals, Inc. | Inflammation-associated genes |
| WO2006138005A2 (en) * | 2005-05-10 | 2006-12-28 | Monsanto Technology, Llc | Genes and uses for plant improvement |
| WO2013033626A2 (en) * | 2011-08-31 | 2013-03-07 | Trustees Of Dartmouth College | Nkp30 receptor targeted therapeutics |
| EP2892930B1 (en) * | 2012-09-07 | 2019-08-14 | University Of Miami | Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof |
| JP7054622B2 (ja) * | 2014-07-21 | 2022-04-14 | ノバルティス アーゲー | ヒト化抗bcmaキメラ抗原受容体を使用した癌の処置 |
| EP3273993A4 (en) * | 2015-03-27 | 2018-11-07 | Nantkwest, Inc. | Genetically modified nk-92 cells and monoclonal antibodies for the treatment of cancer |
| JP7015551B2 (ja) * | 2016-02-23 | 2022-02-15 | ソーク インスティテュート フォー バイオロジカル スタディーズ | ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現 |
| BR112019011277A2 (pt) * | 2016-12-02 | 2019-10-22 | University Of Southern California | polinucleotídeo, sistema de expressão recombinante, vetor, polipeptídeo, célula recombinante, polipeptídeo de receptor imune sintético isolado ou heterodímero de polipeptídeo, célula efetora imune ou célula-tronco, população de células imunes ou efetoras, métodos de fabricação de uma célula efetora imune que expressa sir, de geração de uma população de células modificadas por rna, de fornecimento de imunidade antidoença e de tratamento ou prevenção de uma doença, composição, uso ou método, kit, e, sequência de aminoácidos. |
| CN108728465A (zh) * | 2017-04-14 | 2018-11-02 | 深圳新诺微环生物科技有限公司 | 一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用 |
| JP7241161B2 (ja) * | 2018-08-01 | 2023-03-16 | イミュニティーバイオ、インコーポレイテッド | 細胞免疫療法の安定した遺伝子改変のための、ホーミング受容体又はサイトカインとキメラ抗原受容体とを含むクアドリシストロニックシステム |
-
2022
- 2022-02-21 CA CA3208717A patent/CA3208717A1/en active Pending
- 2022-02-21 JP JP2023551146A patent/JP2024518011A/ja active Pending
- 2022-02-21 WO PCT/US2022/017177 patent/WO2022178367A2/en not_active Ceased
- 2022-02-21 US US18/275,957 patent/US20240390496A1/en active Pending
- 2022-02-21 KR KR1020237031803A patent/KR20230153529A/ko active Pending
- 2022-02-21 EP EP22757078.5A patent/EP4297769A2/en active Pending
- 2022-02-21 AU AU2022224066A patent/AU2022224066A1/en active Pending
- 2022-02-21 IL IL305175A patent/IL305175A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022224066A1 (en) | 2023-09-07 |
| EP4297769A2 (en) | 2024-01-03 |
| IL305175A (en) | 2023-10-01 |
| WO2022178367A3 (en) | 2022-09-29 |
| WO2022178367A2 (en) | 2022-08-25 |
| KR20230153529A (ko) | 2023-11-06 |
| US20240390496A1 (en) | 2024-11-28 |
| JP2024518011A (ja) | 2024-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240390496A1 (en) | Single-chain and multi-chain synthetic antigen receptors for diverse immune cells | |
| US20240083968A1 (en) | Treatment of cancer using chimeric cd3 receptor proteins | |
| JP7599205B2 (ja) | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 | |
| US20230212319A1 (en) | Novel antigen binding domains and synthetic antigen receptors incorporating the same | |
| JP2023145589A (ja) | 共刺激のための新規のプラットフォーム、新規のcar設計、および養子細胞療法のための他の増強 | |
| US20190375815A1 (en) | Treatment of cancer using chimeric t cell receptor proteins having multiple specificities | |
| JP2023085479A (ja) | 合成免疫受容体およびその使用方法 | |
| JP7118887B2 (ja) | 最適化されたレンチウイルス移入ベクターおよびその使用 | |
| AU2021286676B2 (en) | Engineered immune cell expressing NK inhibitory molecule and use thereof | |
| CA3032054A1 (en) | Combination therapies of chimeric antigen receptors and pd-1 inhibitors | |
| WO2021030153A2 (en) | Engineered t cell receptors and uses thereof | |
| WO2018111340A1 (en) | Methods for determining potency and proliferative function of chimeric antigen receptor (car)-t cells | |
| CN117202921A (zh) | 用于多种免疫细胞的单链和多链合成抗原受体 | |
| KR20230155521A (ko) | 면역 세포 기능의 향상 | |
| US20250345429A1 (en) | Compositions and methods comprising chimeric adaptor polypeptides | |
| US20220267420A1 (en) | Foxp3 targeting agent compositions and methods of use for adoptive cell therapy | |
| HK40077828A (en) | Engineered immune cell expressing nk inhibitory molecule and use thereof |